-
Sun Pharmaceutical Industries Share Price Live Updates: Sun Pharmaceutical Industries posts solid gains
(01 Oct 2024)
Join us on the Sun Pharmaceutical Industries Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.
-
Sun Pharma inks global licensing agreement with Philogen
(01 Oct 2024)
Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have entered into a global licensing agreement for...
-
Sun Pharma, Philogen Enter Pact To Commercialise Cancer Medicine Fibromun
(01 Oct 2024)
Sun Pharmaceutical Industries Ltd. has entered into an agreement with Italian-Swiss firm Philogen to commercialise Fibromun—an anti-cancer...
-
Sun Pharmaceutical Industries Share Price Updates: Sun Pharmaceutical Industries Trading Insights
(01 Oct 2024)
Join us on the Sun Pharmaceutical Industries Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.
-
Sun Pharma and Philogen enter into exclusive agreement for commercialising anti-cancer immunotherapy
(01 Oct 2024)
Sun Pharmaceutical Industries Limited and Philogen on Tuesday announced that they have entered into a global licensing agreement for...
-
Sun Pharma Signs Global Licensing Deal for Philogen's Anti-Cancer Immunotherapy, Shares Down 1%
(01 Oct 2024)
Shares of Sun Pharmaceutical Industries Ltd. fell by 1% after reaching a day's high of Rs 1934.75 on 1st October.
-
Stock Market LIVE Updates: Nifty Share Price Today, September 30, 2024
(30 Sep 2024)
The NSE Nifty 50 closed 0.22% lower at 18178.10, shedding 39.35 points from the previous close of 18217.45. The index touched an intraday...
-
Sun Pharmaceutical Industries Stocks Live Updates: Sun Pharma's Price Drop, A Temporary Setback Amidst Mo...
(30 Sep 2024)
Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most...
-
Sun Pharmaceutical Industries (NSE:SUNPHARMA) jumps 4.4% this week, though earnings growth is still tracking behind five-year shareholder returns
(29 Sep 2024)
We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...
-
Sun Pharmaceutical Industries Share Price Live Updates: Sun Pharmaceutical Industries Sees 2.4% Surge, C...
(28 Sep 2024)
Stay updated with the Sun Pharmaceutical Industries Stock Liveblog, your one-stop destination for real-time information and analysis of a...
-
Sun Pharmaceutical Industries Share Price Live Updates: Sun Pharma's Weekly Performance, Rs 1898.40 and 1...
(27 Sep 2024)
Stay updated with the Sun Pharmaceutical Industries Stock Liveblog, your one-stop destination for real-time information and analysis of a...
-
Sun Pharma presents clinical efficacy and safety data in severe dermatological conditions at 2024 EADV Congress
(27 Sep 2024)
Sun Pharmaceutical Industries Limited will present abstracts across its dermatology portfolio at the 33rd European Academy of Dermatology...
-
Stock Market Today , September 27, 2024 LIVE UPDATES: Power Grid Corporation Of India Ltd. Plummets on this trading day
(27 Sep 2024)
In today's trading session on the National Stock Exchange, the Nifty 50 index closed slightly lower by 0.16% at 26175.25.
-
Sell Dr Reddy's, Lupin, Zydus Life, Auro Pharma shares, says UBS, sees up to 20% downside
(27 Sep 2024)
Global brokerage firm UBS has initiated coverage on as many has half dozen Indian Pharma counters and has suggested to sell four out of them...
-
Sun Pharma Advanced Research Com share price range
(27 Sep 2024)
Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing...
-
Lifitegrast API Market Worldwide Major Growth by Key Players – Dr. Reddy’s Laboratories Ltd., Gentec Pharmaceutical Group, Teva API, Sun Pharmaceutical Industries Ltd. – Cauverynews
(26 Sep 2024)
Global Lifitegrast API Market from 2024 to 2032 just released research on the MarketsandResearch.biz. It gives an in-depth understanding of...
-
UBS Issues Buy Rating For Sun Pharma, Cipla; Sell For Zydus, Dr. Reddys Amid Generic Drug Market Concerns
(26 Sep 2024)
UBS highlights growth opportunities for Sun Pharma and Cipla while raising alarms about profitability pressures in the Indian and US generic...
-
UBS starts coverage on Sun Pharma with Buy rating, sees specialty sales doubling
(26 Sep 2024)
UBS has initiated coverage on Sun Pharmaceutical Industries Ltd. (NS:SUN) (SUNP: IN) with a Buy rating and a price target of INR 2,450.00.
-
Sun Pharmaceutical Industries Stocks Live Updates: Sun Pharmaceutical Industries Sees Minor Price Increa...
(24 Sep 2024)
Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most...
-
Ranbaxy shares to stop trading on exchanges from 6 April | Mint
(24 Sep 2024)
Sun Pharma has fixed 7 April as the record date for determining the entitlement of Ranbaxy shareholders to the equity shares of the former.
-
Glenmark’s Telma H, Sun Pharma’s Ursocol 300 among 16 drugs termed spurious | Mint
(22 Sep 2024)
The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they failed the...
-
Glenmark, JB Pharma, Sun, Zydus Lifescience drive pharma market growth in August | Stock Market News
(20 Sep 2024)
Stock Market Today: The Nifty Pharma has gained around 37% year to date. The growth continues to be led by the US sales and well supported...
-
Sun Pharma appoints Tejash Chheda as General Manager - Head of Media
(20 Sep 2024)
Mumbai: Sun Pharmaceutical Industries Ltd. has announced the appointment of Tejash Chheda as the General Manager - Head of Media.
-
Sun Pharmaceutical Industries falls Wednesday, underperforms market
(18 Sep 2024)
shares slid 1.78% to 1,832.65 Indian rupees Wednesday, on what proved to be an all-around dismal trading session for the stock market,...
-
CORRECTING and REPLACING TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm
(17 Sep 2024)
TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm.
-
Sun Pharmaceutical Industries Share Price come in Bullish rally after 1845, add it to watch list now
(17 Sep 2024)
Sun Pharmaceutical Industries Ltd. is a key player in the pharmaceutical sector, with its share price currently experiencing fluctuations...
-
TARO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
(15 Sep 2024)
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors...
-
3 Pharma stocks that earn 90% revenue from international markets
(14 Sep 2024)
The pharmaceutical business is a critical component of the healthcare sector, responsible for drug research, development, manufacture,...
-
Sun Pharmaceutical Industries Stocks Live Updates: Sun Pharmaceutical Industries Sees Incremental Gains ...
(12 Sep 2024)
Discover the Sun Pharmaceutical Industries Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a...
-
Sun Pharmaceutical Industries rises Thursday, still underperforms market
(12 Sep 2024)
rose 1.00% to 1,864.95 Indian rupees Thursday, on what proved to be an all-around positive trading session for the stock market,...
-
Private companies account for 43% of Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) ownership, while institutions account for 28%
(11 Sep 2024)
Key Insights Sun Pharmaceutical Industries' significant private companies ownership suggests that the key decisions are...
-
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants
(11 Sep 2024)
PRNewswire/ -- Ademi LLP announces that a class action lawsuit has been filed on September 9, 2024 in the United States District Court for...
-
Stocks To Buy: Sun, Coal India, ITC, HUL among 10 inclusions to Buy list by Jefferies for September | Stock Market News
(11 Sep 2024)
Stocks to Buy: Coal India, ITC Ltd , Hindustan Unilever Ltd (HUL), Sun Pharmaceutical Industries, Cholamandalam Investment and Finance...
-
Jefferies' Top Picks for September: Coal India, HUL, ITC, Sun Pharma Among 10 Must-Buy Stocks
(11 Sep 2024)
Jefferies' Top Picks for September: Coal India, HUL, ITC, Sun Pharma Among 10 Must-Buy Stocks, Jefferies has added 10 new stocks to its Buy...
-
Sun Pharma and Moebius gain FDA fast track for osteoarthritis drug
(09 Sep 2024)
Sun Pharmaceutical Industries (Sun Pharma) and Moebius Medical have received fast track designation (FTD) from the US Food and Drug...
-
Motion Sickness Treatment Market to See Stunning Growth
(09 Sep 2024)
HTF Market Intelligence published a new research document of 150+pages on Motion Sickness Treatment Market Insights, to 2030″ with...
-
Sun Pharmaceutical Industries falls Friday, still outperforms market
(07 Sep 2024)
inched down 0.07% to 1,823.35 Indian rupees Friday, on what proved to be an all-around poor trading session for the stock market,...
-
Sun Pharmaceutical Industries Limited Receives an Order Passed by Regional Director, North Western Region, Ministry of Corporate Affairs
(07 Sep 2024)
Sun Pharmaceutical Industries Limited received an order passed by Regional Director, North Western Region, Ministry of Corporate Affairs.
-
Sun Pharma, Moebius Medical gets USFDA FTD to MM-II
(06 Sep 2024)
Sun Pharmaceutical Industries and Moebius Medical said that the United States Food and Drug Administration (USFDA) has granted Fast Track...
-
Sun Pharma stocks: Buy Sun Pharmaceutical Industries, target price Rs 1995: JM Financial
(05 Sep 2024)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 439762.11 Crore)...
-
Buy Sun Pharmaceutical Industries, target price Rs 1995: JM Financial
(05 Sep 2024)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 439762.11 Crore)...
-
Large Cap Pharma Stock To Buy In September For TP Rs 1995, Recommends JM Financial
(05 Sep 2024)
Brokerage firm JM Financial has recommended investors to buy shares of large cap pharmaceuticals company Sun Pharmaceutical Industries Ltd...
-
ICICI Bank, Bajaj Finance and Sun Pharma delivered consistent profit growth for last four quarters
(02 Sep 2024)
ICICI Bank, Bajaj Finance and Sun Pharma showcase consistent growth, attracting investors confidence. Their strong fundamentals and...
-
Top Stocks to Invest in August 2024 on MintCFD: Expert Picks
(31 Aug 2024)
Find out the list of top stocks up trade in August 2024. Trade all the stocks on MintCFD, a platform with maximum trading benefits in India.
-
Sun Pharmaceutical Industries Limited Receives Order from Assistant Commissioner of State Tax Raipur Division, Chattisgarh and Joint Commissioner Secunderabad, Telangana
(31 Aug 2024)
Sun Pharmaceutical Industries Limited has received an order passed by statutory authority. Name of the authority is Assistant Commissioner...
-
Sun Pharmaceutical Industries Limited Receives an Order from Asst. Commissioner Madurantagam Assessment Chengalpattu, Tamilnadu
(30 Aug 2024)
Sun Pharmaceutical Industries Limited received an order from Asst. Commissioner Madurantagam assessment Chengalpattu, Tamilnadu.
-
Who is the Indian billionaire taking 4,500 employees on a tour to Vietnam?
(27 Aug 2024)
Dilip Shanghvi, the billionaire set to take 4500 of his employees on a tour to Vietnam this week, is the founder of Sun Pharmaceutical...
-
Buy Sun Pharmaceutical Industries, target price Rs 1895: JM Financial
(26 Aug 2024)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 426061.91 Crore)...
-
Nicoumalone Market Is Booming Worldwide 2024-2032 | Aurobindo
(26 Aug 2024)
Press release - WiseGuy Reports - Nicoumalone Market Is Booming Worldwide 2024-2032 | Aurobindo Pharma USA, Inc., Alkem Laboratories Ltd.,...
-
Pinning Down Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) P/E Is Difficult Right Now
(24 Aug 2024)
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 33x, you may consider Sun...
-
Best Pharma stocks in India to add to your watchlist in 2024
(23 Aug 2024)
Health plays a vital role in human life, shaping our daily experiences. As we face various health challenges, the pharmaceutical industry is...
-
Sun Pharma launches novel therapy for skin disorders in India
(23 Aug 2024)
Sun Pharmaceutical Industries Limited on Friday announced that it has launched Tedizolid Phosphate tablets 200 mg in India under the brand...
-
Sun Pharmaceutical Industries Share Price Today Live Updates: Sun Pharmaceutical Industries Sees Modest ...
(23 Aug 2024)
Stay up-to-date with the Sun Pharmaceutical Industries Stock Liveblog, your comprehensive source for real-time updates and detailed analysis...
-
Sun Pharma hits 52-week high on launch of skin infection drug 'Starizo'
(23 Aug 2024)
Sun Pharma stock hits 52-week high: Shares of pharmaceutical company Sun Pharma rose as much as 1.76 per cent to hit a fresh 52-week high of...
-
Sun Pharma launches STARIZO for drug-resistant skin infections, shares at 52-week high
(23 Aug 2024)
Shares of Sun Pharmaceutical Industries extended gains and rose 1.8 percent to a 52-week high of Rs 1,781.5 on August 23 after the company...
-
Sun Pharma hits record high on launching skin infection drug, Starizo
(23 Aug 2024)
Sun Pharmaceutical Industries advanced 1.71% to Rs 1780.50 after the company announced that it has launched Tedizolid Phosphate tablets in...
-
Sun Pharma Introduces Novel Treatment, Tedizolid Phosphate in India for Acute Bacterial Skin and Skin Structure Infection
(23 Aug 2024)
Sun Pharmaceutical Industries Limited announced that it has launched Tedizolid Phosphate tablets 200 mg in India under the brand name...
-
India's top 5 pharma stocks by growth | Stock Market News
(23 Aug 2024)
As India cements its status as the "pharmacy of the world," its pharmaceutical giants are not just keeping pace—they're setting the pace.
-
Mann firms up mega investment projects for Punjab
(22 Aug 2024)
Chandigarh: Punjab Chief Minister Bhagwant Singh Mann on Wednesday secured major investment commitments from leading companies including Sun...
-
Punjab eyes investments as CM Mann meets industry leaders in Mumbai
(22 Aug 2024)
Punjab Chief Minister Bhagwant Mann successfully attracts investments from leading companies like Sun Pharmaceutical Industries Ltd, RPG,...
-
Punjab CM Bhagwant Mann meets industry captains in Mumbai, bags mega projects
(22 Aug 2024)
Mumbai, August 21 Punjab Chief Minister Bhagwant Mann on Wednesday firmed up major investment projects for the state, with leading companies...
-
Mumbai: Mann firms up mega investment projects for Punjab, meets top honchos in the industry
(22 Aug 2024)
Photo Source: Babushahi Bureau. CM Mann firms up mega investment projects for Punjab, meets top honchos in the industry during a visit to...
-
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
(21 Aug 2024)
Strategic equity investment of $15 M to support completion of Pharmazz's pivotal Phase 3 study for Sovateltide to treat patients with acute...
-
Stock market update: Nifty Pharma index advances 0.7% in a weak market
(21 Aug 2024)
The Nifty Pharma index was trading 0.7 per cent up at 22530.15.
-
CM Mann meets industry honchos in Mumbai, firms up Mega Investment Projects for State
(21 Aug 2024)
Mumbai, August 21, 2024 (Yes Punjab News). Punjab Chief Minister Bhagwant Singh Mann on Wednesday firmed up major investment projects for state with leading...
-
NEWS RECEIVED FROM PUNJAB STATE UNDER THE LEADERSHIP OF C.M.SH.BHAGWANT SINGH MANN
(21 Aug 2024)
CM FIRMS UP MEGA INVESTMENT PROJECTS FOR STATE. * MEETS TOP HONCHOS ON INDUSTRY DURING VISIT TO MUMBAI. * SUN PHARMA SHOWS KEENNESS TO...
-
CM meets industry honchos, firms up investment projects for Punjab
(21 Aug 2024)
Punjab CM Bhagwant Mann secured major investments from Sun Pharma, RPG, Sify Technologies, and JSW Group, highlighting the state's potential...
-
Edaravone Market Report Analysis, Research Studies | Sun
(20 Aug 2024)
Press release - DataM intelligence 4 Market Research LLP - Edaravone Market Report Analysis, Research Studies | Sun Pharmaceutical...
-
Oxaliplatin Industry to Witness Massive Growth (2024-2031) |
(20 Aug 2024)
DataM Intelligence has published a new research report on "Oxaliplatin Market Size 2024". The report explores comprehensive and insightful...
-
Sun Pharmaceuticals Industries Ltd spurts 0.31%, up for fifth straight session
(20 Aug 2024)
Sun Pharmaceuticals Industries Ltd is quoting at Rs 1753.25, up 0.31% on the day as on 12:44 IST on the NSE. The stock is up 54.15% in last...
-
Imatinib Drug Market Report Analysis, Research Studies | Sun
(19 Aug 2024)
Press release - DataM Intelligence - Imatinib Drug Market Report Analysis, Research Studies | Sun Pharmaceutical Industries Ltd.,...
-
Sun Pharma to buy over 5 percent stake in Pharmazz for up to USD 15 million
(17 Aug 2024)
Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Pharmazz Inc. Delaware US, pursuant to which the Company...
-
Accumulate Sun Pharmaceutical Industries; target of Rs 1827: KR Choksey
(16 Aug 2024)
KR Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1827 in its research report dated August...
-
Sun Pharmaceutical Industries rises Friday, still underperforms market
(16 Aug 2024)
shares inched up 0.06% to 1,742.55 Indian rupees Friday, on what proved to be an all-around positive trading session for the stock market,...
-
Fed. Cir. Nixes Sun Pharma’s Win Axing Allergan IBS Drug Patents
(14 Aug 2024)
The Federal Circuit overturned Sun Pharmaceutical Industries Ltd.'s win invaliding five patents linked to Viberzi, the irritable bowel...
-
Sun Pharmaceutical Industries rises Wednesday, still underperforms market
(14 Aug 2024)
inched up 0.10% to 1,741.50 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market,...
-
Sun Pharmaceutical Industries rises Tuesday, outperforms market
(13 Aug 2024)
inched up 0.41% to 1,739.75 Indian rupees Tuesday, on what proved to be an all-around grim trading session for the stock market,...
-
Sun Pharmaceutical Industries falls Monday, underperforms market
(12 Aug 2024)
inched down 0.15% to 1,732.70 Indian rupees Monday, on what proved to be an all-around grim trading session for the stock market,...
-
Sun Pharma, Cipla among top picks by Ajit Mishra of Religare Broking
(08 Aug 2024)
Markets experienced a breather after the recent decline, gaining over a percent, driven by strong global cues.
-
Sun Pharma to shell out `2,517 cr to settle patent suit | Company Business News
(07 Aug 2024)
Mumbai: Sun Pharmaceutical Industries Ltd has said it will pay its dues of ₹ 2,517.41 crore soon as part of a settlement agreement with...
-
Akums Drugs and Pharma IPO listing: Shares list at 6.7% premium to issue price on NSE & BSE
(06 Aug 2024)
Akums Drugs and Pharma IPO consists of a fresh issue of shares valued at ₹680 crore and an offer-for-sale (OFS) component of 1.73 crore...
-
Sun Pharmaceutical Industries falls Tuesday, underperforms market
(06 Aug 2024)
shares inched down 0.76% to 1,707.00 Indian rupees Tuesday, on what proved to be an all-around grim trading session for the stock market,...
-
Sun Pharmaceutical Industries Limited Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next
(06 Aug 2024)
Last week saw the newest first-quarter earnings release from Sun Pharmaceutical Industries Limited ( NSE:SUNPHARMA...
-
Buy Sun Pharmaceutical Industries; target of Rs 1885: Prabhudas Lilladher
(03 Aug 2024)
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1885 in...
-
Taro integration underway, no major structural changes, says Sun Pharma CMD
(03 Aug 2024)
Sun Pharma completes Taro Pharma merger, focusing on integration and growth, with positive financial performance in Q1 FY 25.
-
Sun Pharmaceutical Industries First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
(03 Aug 2024)
Sun Pharmaceutical Industries ( NSE:SUNPHARMA ) First Quarter 2025 Results Key Financial Results Revenue: ₹126.5b (up...
-
Pharma Stock To Buy After Q1 Net Profit Soars 40%, TP Rs 1885: PL Recommends
(03 Aug 2024)
Sun Pharmaceutical Industries Ltd shares have been hitting back-to-back 52-week high in trade on BSE for the last few days.
-
Sun Pharmaceutical's Leqselvi faces legal challenges in US launch
(02 Aug 2024)
Sun Pharmaceutical Industries Ltd's alopecia drug, Leqselvi (Deuruxolitinib), recently approved by the USFDA, faces immediate legal...
-
Sun Pharma Q1 Results: Net profit jumps 40% to ₹2,836 crore, revenue up 6% YoY | Company Business News
(02 Aug 2024)
Sun Pharma Q1 Results: Sun Pharmaceutical Industries on Thursday reported a consolidated net profit growth of 40.2% year-on-year (YoY) at...
-
Sun Pharmaceutical Q1 Results: Profit Jumps 40%, Beats Estimates
(02 Aug 2024)
Sun Pharmaceutical Industries Ltd.'s Q1 FY25 results exceeded expectations, with a 40% jump in net profit to Rs 2835.62 crore and a 6%...
-
Indian drugmaker Sun Pharma posts Q1 profit beat on strong local sales
(02 Aug 2024)
Sun Pharmaceutical , India's largest drugmaker by revenue, reported first-quarter profit above analysts' estimates on Thursday,...
-
Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
(02 Aug 2024)
Sun Pharmaceutical Industries Limited reported earnings results for the first quarter ended June 30, 2024. For the first quarter,...
-
Sun Pharma Q1 Net Profit Surges 40.2% to Rs 2,835.62 cr
(02 Aug 2024)
New Delhi, Aug 1 (PTI) Sun Pharmaceutical Industries Ltd on Thursday reported a 40.2 per cent jump in consolidated net profit to Rs 2,835.62...
-
Sun Pharma maintains topline growth guidance for all businesses
(02 Aug 2024)
CS Muralidharan, Group CFO of Sun Pharmaceutical Industries, told CNBC-TV18 that all businesses are well-positioned for growth at this point...
-
Sun Pharma Q1 net profit jumps 40.2 pc to Rs 2,835.62 cr
(02 Aug 2024)
New Delhi, Aug 1 (PTI) Sun Pharmaceutical Industries Ltd on Thursday reported a 40.2 per cent jump in consolidated net profit to Rs 2835.62 crore for the...
-
Tata Motors, Adani Enterprises, ITC, Sun Pharmaceuticals Q1 Results Today — Earnings Estimates
(01 Aug 2024)
Tata Motors Ltd., Adani Enterprises Ltd., and ITC Ltd. will be among the major companies to report their first-quarter earnings on Thursday.
-
Q1 results today: Adani Enterprises, Tata Motors, ITC, Sun Pharma, Zomato, others to post earnings on August 1; check list
(01 Aug 2024)
Q1 results today: Adani Ports & SEZ, Dabur India, Kalyan Jewellers India, Aditya Birla Capital, Thermax, Triveni Engineering & Industries,...
-
Q1 Results Live Updates: Tata Motors, Adani Enterprises, ITC, Sun Pharma Report Cards Today
(01 Aug 2024)
Tata Motors Ltd., Adani Enterprises Ltd., and ITC Ltd. will be among the major companies to report their first-quarter earnings on Thursday.
-
Is it the right time to buy Sun Pharma? How does the future look like
(01 Aug 2024)
The pharmaceutical sector is one of the most dynamic sectors in India. Pharmaceutical products are focused on drugs, sprays, ointments,...
-
Sun Pharma's Leqselvi faces legal challenges in US launch
(01 Aug 2024)
Sun Pharmaceutical Industries Ltd's alopecia drug, Leqselvi (Deuruxolitinib), recently approved by the USFDA, faces immediate legal...
-
Sun Pharma Q1 Results: Net profit at 40.2% year-on-year
(01 Aug 2024)
Sun Pharma Q1 Results Today: Sun Pharmaceutical Q1FY25 net profit came in at at Rs 2835.62 crore, up 40.2% from Rs 2022.54 crore in Q1FY24.
-
Sun Pharma Q1 results: Profit zooms 40% on robust global specialty sales
(01 Aug 2024)
On a sequential basis, the company exhibited a 6.8 per cent rise in net profit, while its revenue grew by 5.5 per cent, from Rs 2655 crore...
-
Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates
(01 Aug 2024)
Sun Pharmaceutical Industries reported on 1 August its Q1 FY25 net profit rose 40 percent on-year to Rs 2,836 crore from Rs 2,023 crore in...
-
Sun Pharma Q1 Preview: Strong US, domestic sales to aid profit growth but high R&D to drag margins
(31 Jul 2024)
Drugmaker Sun Pharmaceutical Industries is all set to release its April-June quarter earnings for FY25 on August 1.
-
Sun Pharmaceutical Industries Stocks Live Updates: Sun Pharma's Stock Sees Incremental Rise: Current Pric...
(31 Jul 2024)
Join us on the Sun Pharmaceutical Industries Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.
-
This Is The Reason Why We Think Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) CEO Might Be Underpaid
(30 Jul 2024)
Key Insights Sun Pharmaceutical Industries' Annual General Meeting to take place on 5th of August CEO Dilip Shanghvi's...
-
Is Sun Pharmaceutical Industries Limited's (NSE:SUNPHARMA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
(30 Jul 2024)
Sun Pharmaceutical Industries (NSE:SUNPHARMA) has had a great run on the share market with its stock up by a...
-
Sun Pharmaceutical Industries outperforms competitors despite losses on the day
(30 Jul 2024)
Shares of Sun Pharmaceutical Industries Ltd. dropped 1.30% to 1701.65 Indian rupees Tuesday, on what proved to be an all-around favorable...
-
FDA Approves Sun Pharma’s LEQSELVI To Treat Severe Alopecia Areata
(29 Jul 2024)
Sun Pharmaceutical Industries Ltd. received approval from the FDA for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults...
-
Q1 results: SBI, Tata Steel, Coal India, BHEL, Pfizer, and Sun Pharma among companies to declare earnings next week | Stock Market News
(28 Jul 2024)
Q1 results: Pfizer, Adani Wilmar, Tata Consumer Products, Varun Beverages, Tata Steel, Coal India, BHEL, Tata Motors, Sun Pharma, Dabur,...
-
U.S. FDA Approves LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
(26 Jul 2024)
LEQSELVI delivered statistically significant efficacy across two Phase 3 clinical trials. At baseline, the average patient had only 13%...
-
Sun Pharma's drug to treat alopecia areata gets USFDA nod
(26 Jul 2024)
Sun Pharmaceutical Industries Ltd announced that the USFDA has approved its drug LEQSELVI (deuruxolitinib) for treating adults with severe...
-
Sun Pharma gets US FDA nod for alopecia areata treatment drug LEQSELVI
(26 Jul 2024)
Sun Pharmaceutical Industries said that it has received approval from the U.S. Food and Drug Administration (US FDA) for LEQSELVI...
-
USFDA approves Sun Pharma's drug to treat alopecia areata
(26 Jul 2024)
Sun Pharmaceutical Industries Ltd on Friday said the US health regulatory has approved its LEQSELVI (deuruxolitinib) drug for the treatment...
-
Sun Pharmaceutical Industries Limited Receives Approval from U.S. Food and Drug Administration for LEQSELVITM (deuruxolitinib), an Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata
(26 Jul 2024)
Sun Pharmaceutical Industries Limited informed that they have received approval from the U.S. Food and Drug Administration for LEQSELVITM...
-
Stock Market Live Updates: Markets open higher; NIFTY50 up 0.21%; SENSEX gains 140 points
(26 Jul 2024)
Benchmark indices opened higher on Friday, with NIFTY50 up 0.21% and SENSEX gaining 140 points. In the NIFTY50 space, 40 stocks were...
-
Sun Pharma Receives USFDA Approval for Alopecia Treatment Drug; Shares Jump 3%
(26 Jul 2024)
Shares of Sun Pharmaceutical Industries Ltd. surged by almost 3% to touch a day's high of Rs 1712.40 on 26 July after announcing USFDA...
-
Sun Pharma's Hair Loss Drug Approved by USFDA
(26 Jul 2024)
Sun Pharmaceutical Industries Ltd announced on Friday that its LEQSELVI (deuruxolitinib) medicine has been authorised by the US FDA for the...
-
Cipla, Divis Labs Lead Pharma Stocks Rally To New High
(26 Jul 2024)
The Nifty Pharma was the top sectoral gainer this week, led by Granules India, Biocon, and Sun Pharmaceutical Industries.
-
Stock market update: Nifty Pharma index advances 1.86% in an upbeat market
(26 Jul 2024)
NEW DELHI: The Nifty Pharma index traded positive around 11:20AM(IST)on Friday in an upbeat market. ADVERTISEMENT. Ad. Laurus Labs Ltd.(up...
-
Sun Pharmaceutical Industries rises Friday, outperforms market
(26 Jul 2024)
Sun Pharmaceutical Industries Ltd. shares rose 2.91% to 1713.60 Indian rupees Friday, on what proved to be an all-around positive trading...
-
FDA approves Sun Pharma’s JAK inhibitor for alopecia
(26 Jul 2024)
The FDA approval is based on data gathered from two Phase III studies where over 30% of the patients gained 80% or more coverage of scalp...
-
Sun Pharma gets USFDA nod for its formulation to treat Severe Alopecia Areata
(26 Jul 2024)
Sun Pharmaceutical Industries Limited on Friday announced that the U.S. Food and Drug Administration (FDA) approved LEQSELVI...
-
USFDA Approves Sun Pharma's Alopecia Areata Drug - LEQSELVI
(26 Jul 2024)
New Delhi, Jul 26 (PTI) Sun Pharmaceutical Industries Ltd on Friday said the US health regulatory has approved its LEQSELVI (deuruxolitinib)...
-
Sun Pharma shares hit 52-week high after USFDA approval for Alopecia treatment drug
(26 Jul 2024)
The drug is an Oral JAK Inhibitor for the treatment of severe alopecia areata, the company informed the stock exchanges.
-
Sun Pharma receives US FDA approval for drug to treat alopecia areata
(26 Jul 2024)
Sun Pharmaceutical Industries has received US Food and Drug Administration (FDA) approval for LEQSELVI (deuruxolitinib) that is used for...
-
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
(25 Jul 2024)
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for...
-
Sun Pharmaceutical Industries - These 10 stocks hit a 52-week high and rallied up to 25% in a month
(25 Jul 2024)
New 52-week of high: Rs 1681|CMP: Rs 1665.2. In the last one month stock has gained about 11%. Sun Pharmaceutical Industries.
-
Sun Pharma Advanced Research Company Share Price
(25 Jul 2024)
1. What's the Sun Pharma Advanced Research Company Ltd share price today? Sun Pharma Advanced Research Company Ltd share price was Rs 226.90 at...
-
Sun Pharmaceuticals Industries Share Price
(25 Jul 2024)
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic...
-
Cipla To Sun Pharma: gRevlimid To Drive Q1 Sales Growth For Pharma, Say Analysts
(24 Jul 2024)
Indian pharmaceutical companies are expected to see sales growth in the first quarter of fiscal 2025, as analysts foresee contributions from...
-
Sun Pharmaceutical Industries rises Wednesday, outperforms market
(24 Jul 2024)
Shares of Sun Pharmaceutical Industries Ltd. advanced 1.08% to 1619.75 Indian rupees Wednesday, on what proved to be an all-around dismal...
-
Sun Pharmaceuticals Industries Ltd rises for third straight session
(24 Jul 2024)
Sun Pharmaceuticals Industries Ltd is quoting at Rs 1620, up 1.15% on the day as on 12:49 IST on the NSE. The stock is up 47.94% in last one...
-
Sun Pharmaceutical Industries outperforms competitors on strong trading day
(23 Jul 2024)
Sun Pharmaceutical Industries Ltd. shares inched up 0.91% to 1602.40 Indian rupees Tuesday, on what proved to be an all-around grim trading...
-
Weekly Overview| Supreme Court Judgments: July 15 – July 19, 2024
(22 Jul 2024)
1) DPCO provisions cannot be given restricted interpretation: SC rejects Sun Pharmaceuticals' claim that it is not 'distributor' of roscilox...
-
Sun Pharmaceutical Industries Share Price Today Updates: Sun Pharma's Stock Price Dips by 1.64% Amid Incr...
(20 Jul 2024)
Welcome to the Sun Pharmaceutical Industries Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a...
-
Sun Pharmaceutical Industries falls Friday, underperforms market
(19 Jul 2024)
Sun Pharmaceutical Industries Ltd. shares shed 1.58% to 1568.45 Indian rupees Friday, on what proved to be an all-around dismal trading...
-
SC upholds NPPA's Rs 4.6 crore penalty on Sun Pharma
(18 Jul 2024)
India Business News: Sun Pharmaceutical Industries Ltd, the sixth-largest generic pharmaceutical manufacturer in the world, had questioned...
-
Oops, They Did It Again: Indian Pharma’s Frequent Flyers on FDA's Naughty List
(18 Jul 2024)
The U.S. Food and Drug Administration (FDA) is a federal agency responsible for protecting public health by ensuring the safety, efficacy,...
-
Drugs (Price Control) Order | Supreme Court Upholds Rs 4.6 Crore Recovery Against Sun Pharma For...
(18 Jul 2024)
The Supreme Court on Monday (July 15) observed that the purpose of Drugs (Price Control) Order, 1995 (DPCO) is to control prices of...
-
Dilip Shanghvi displaces Mukesh Ambani as India’s richest person | Company Business News
(18 Jul 2024)
Mumbai: Sun Pharmaceutical Industries Ltd founder Dilip S. Shanghvi on Wednesday overtook Reliance Industries Ltd's Mukesh Ambani as India's...
-
DPCO Provisions Cannot Be Given Restricted Interpretation: SC Rejects Sun Pharmaceuticals' Claim That It Is Not ‘Distributor’ Of Roscilox Drug
(16 Jul 2024)
The Supreme Court held that Sun Pharmaceuticals Industries Limited is both 'distributor' and 'dealer' of Roscilox, a Cloxacillin-based drug...
-
Announcements Updates: Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
(15 Jul 2024)
Stay informed with the Sun Pharmaceutical Industries Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis...
-
Supreme Court dismisses Sun Pharma's plea on excess price of drug 'Roscilox'
(15 Jul 2024)
New Delhi: The Supreme Court on Monday said there can't be restricted or hidebound interpretation of the Drugs (Price Control) Order, 1995,...
-
Sun Pharmaceutical Industries outperforms market on strong trading day
(11 Jul 2024)
Shares of Sun Pharmaceutical Industries Ltd. inched up 0.71% to 1597.50 Indian rupees Wednesday, on what proved to be an all-around dismal...
-
F&O Stock Strategy: How to trade Sun Pharma and M&M?
(10 Jul 2024)
Sun Pharma and M&M stocks exhibit bullish momentum with potential for gains. Technical and derivative factors support upward movement,...
-
Option strategy of the day | Long additions in Sun Pharma; use bull call spread for upside
(09 Jul 2024)
Sun Pharmaceutical Industries Ltd shares have confirmed a pattern of higher highs and higher lows, signaling bullish momentum.
-
Sun Pharma open to exploring acquisitions in global specialty portfolio
(08 Jul 2024)
Sun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline.
-
Sun Pharma share price rises 25% ytd. Should you Buy, Sell or Hold the stock considering regulatory overhang? | Stock Market News
(08 Jul 2024)
Stock Market Today: Sun Pharmaceutical Industries Ltd has seen its share price rise almost 25% year-to-date. The Sun Pharma share price...
-
Stocks to buy: Sun Pharma, Bank of Baroda, Bharat Forge among analysts' top picks
(08 Jul 2024)
Stocks to buy today, July 5, 2024: On the top analysts' 'buy' list are stocks such as Sun Pharma (SUNPHARMA), Bank of Baroda (BANKBARODA),...
-
Top 10 pharma companies in India by market cap
(08 Jul 2024)
Discover the top pharmaceutical companies in India listed on the NSE, sorted from highest to lowest by market cap.
-
Sun Pharma and Takeda introduces Voltapraz drug in India
(24 Jun 2024)
Sun Pharma partners with Takeda to market Vonoprazan in India, a new treatment for gastrointestinal disorders.
-
Sun Pharma completes Taro merger, acquires all outstanding shares
(24 Jun 2024)
Sun Pharmaceutical Industries on Monday announced the successful completion of the merger of Taro Pharmaceutical Industries with its...
-
USFDA issues warning letter to Sun Pharma's Dadra unit; stock slips 2%
(19 Jun 2024)
Sun Pharmaceuticals Share Price: The fall came after the company announced that it has received a warning letter from USFDA for current Good...
-
Buy Sun Pharma, target price Rs 1710: Prabhudas Lilladher
(17 Jun 2024)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 369329.63 Crore)...
-
Sun Pharma Q4 results: Net profit rises 34% to Rs 2,654.5 crore, final dividend of Rs 5 announced
(15 Jun 2024)
Sun Pharmaceutical Industries Ltd. is a leading Indian pharmaceutical company involved in developing, manufacturing and marketing...
-
Israel-based Taro's shareholders approve merger with Sun Pharmaceutical
(15 Jun 2024)
Shares of Sun Pharmaceutical Industries Ltd ended at ₹1494.95, down by ₹45.35, or 2.94% on the BSE.
-
Address At The Inauguration Of The Research Centre Of Sun Pharmaceutical Industries Ltd., Vadodara
(07 Jun 2024)
When they converge, we get Bio-informatics and the important science of proteomics emerged has revolutionized the drug design. Now with the...
-
Sun Pharmaceutical Industries Q4 Results Live : profit rise by 33.77% YOY | Company Business News
(23 May 2024)
Sun Pharmaceutical Industries Q4 Results Live : Revenue increased by 9.63% YoY & profit increased by 33.77% YoY.
-
Taro shareholders approve merger with Sun Pharma, ending long-drawn feud
(23 May 2024)
Shareholders of Taro Pharmaceutical Industries have approved a merger agreement with Sun Pharmaceutical Industries, bringing to a close, an over 10-year-long...
-
Sun Pharma posts net profit of ₹2,654.58 crore in January-March quarter
(22 May 2024)
Sun Pharma reports strong financial results with increased net profit and revenue, plans to expand specialty portfolio.
-
Sun Pharmaceutical Industries Q4 Results: Profit Rises 34%, Beats Estimates
(22 May 2024)
Sun Pharmaceutical Industries Ltd.'s consolidated net profit increased 33.8% in the fourth quarter of fiscal 2024, and surpassed analysts'...
-
Sun Pharma Q4 net rises 34% to ₹2,654 crore
(22 May 2024)
Sun Pharmaceutical Industries Ltd. reported consolidated FY24 Q4 net profit grew 34% to ₹2,654 crore from ₹1,984 crore in the year earlier...
-
Buy Sun Pharmaceutical Industries, target price Rs 1870: Motilal Oswal
(24 Apr 2024)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 356217.27 Crore)...
-
Sun Pharmaceuticals Industries Share Price Highlights: Stock lost 3.59% during today's trading session; Check price range, day's high and low
(23 Apr 2024)
Sun Pharmaceuticals Industries Ltd Stock Price Live: The Sun Pharmaceuticals Industries Ltd has been in focus today amid company-specific...
-
Buy or sell: Ruchit Jain of 5paisa recommends buying Sun Pharmaceutical Industries and Nykaa today | Stock Market News
(26 Mar 2024)
Buy or sell stocks: Ruchit Jain of 5paisa has recommended two stocks to buy today - Sun Pharmaceutical Industries Ltd and FSN E-Commerce...
-
Buy or sell: Ruchit Jain of 5paisa recommends buying Sun Pharmaceutical Industries and Nykaa today
(26 Mar 2024)
Buy or sell stocks: Ruchit Jain of 5paisa has recommended two stocks to buy today - Sun Pharmaceutical Industries Ltd and FSN E-Commerce...
-
Sun Pharma Q3 results: Net profit up 17% YoY at Rs 2,524 crore; stock hits one-year high
(31 Jan 2024)
Sun Pharma Q3 results: The company's consolidated profit after tax came at Rs 2523.75 crore for the quarter ended December 31, 2023,...